In vitro susceptibilities of ten clinical isolates, including five strains of Cryptococcus neoformans var. grubii and five strains of Aspergillus fumigatus, were determined against nine sulfa drugs using a microdilution method. Among the five tested media, minimum inhibitory concentration MIC values were observed only in YNB medium: no detectable level MIC value of less than 125 g/ml was observed in the four remaining media against Cryptococcus species. Of the nine sulfa drugs, of which sulfaphenazole showed the highest antifungal activity, the MIC values for A. fumigatus and C. neoformans var. grubii were, respectively, 64 g/ml and 4-8 g/ml, suggesting high susceptibility of C. neoformans to sulfa drugs.
Introduction
Opportunistic infections are becoming common because of the growing number of immunocompromised individuals 1 . Recently, opportunistic fungal infections have also become a problem 2, 3 . Particularly, invasive fungal infections attributable to Aspergillus fumigatus and Cryptococcus neoformans have increased considerably in frequency among immunocompromised hosts, engendering excessive morbidity and mortality 4 7 . The high mortality of aspergillosis and cryptococcosis is partly attributable to shortage of highly useful drugs with lower side effects and to the emergence of drug resistance at high rates 8 10 .
Sulfa drugs are metabolic inhibitors of folic acid in microorganisms. The drug combination of sulfamethoxazole SXT -trimethoprim TMP , is an antimicrobial agent that is frequently used for prophylaxis to prevent Pneumocystis carionii Pneumocystis jeroveci pneumonia in AIDS patients and in other immunocompromised individuals 11 13 . In addition, the chemotherapeutic usefulness of sulfa drugs against infections caused by fungus Paracoccidioides brasiliensis has been reported 14, 15 16, 17 . The MIC value was determined visually in comparison with broth control after 48 h of incubation at 37 C; it was defined as the lowest drug concentration resulting in 90% reduction of turbidity when compared with the drug-free control. Table 1 shows that the antifungal activities of sulfamethoxazole were comparatively high in YNB medium, and the MIC values of most of the strains were 31-62 g/ml for Cryptococcus species, except for one strain. However, MIC values in the remaining four tested media were greater than 125-250 g/ml. The higher activity in YNB was considered to be due to the synthetic media that does not contain PABA or PABA related compounds while the other four tested media are organic ones rich in PABA or related compounds. These studies indicated the usefulness of YNB medium for measurement of MIC values in sulfa drugs. An interesting observation was the markedly lower susceptibility of C. gatti strains to sulfamethoxazole than those of C. neoformans var. grubii and C. neoformans var. neoformans strains. Because few C. gatti strains were used two strains , further detailed studies of susceptibility differences among these different varieties and species in Cryptococcus using numerous strains would be of interest. YNB medium was also used as a MIC determination medium in the subsequent experiment because of reproducible MIC values obtained in our first experiment. fumigatus IFM 53412, 51126, 48051, 47450, and 41362 , were used in this experiment.
The following nine sulfa drugs were used: sulfamonomethoxine SMM; Daiichi Pharmaceutical Co., Ltd., Tokyo , sulfadimethoxine SDM; Daiichi Pharmaceutical Co., Ltd. , sulfadiazine SDZ; Daiichi Pharmaceutical Co., Ltd. , sulfamethoxazole SMX; Sigma-Aldrich Corp. , sulfisoxazole SSX; Sigma-Aldrich Corp. , sulfaphenazole SPZ; SigmaAldrich Corp. , sulfisomidine SSM; Kanto Kagaku, Tokyo , sulfamethizole SMT; Sigma-Aldrich Corp. , and sulfamethoxypyridazine SMP; Sigma-Aldrich Corp. . The final concentrations of the sulfa drugs used for antifungal activity tests were 4-256 g/ml.
The susceptibility profiles of five isolates for A. fumigatus and C. neoformans var. grubii are summarized in Table 2 , which shows that five strains of A. fumigatus were moderately susceptible to sulfamonomethoxine, sulfadimethoxine, and sulfadiazine, but that C. neoformans was not susceptible. Sulfisomidine, sulfamethizole and sulfamethoxypyridazine showed lower activity, and their MIC values against A. fumigatus, in addition to C. neoformans var. grubii are 128-256 g/ml. Sulfamethoxazole and sulfisoxazole showed moderate activity against both strains of C. neoformans var. grubii and A. fumigatus: their MIC values were 32-128 g/ml. Among nine sulfa drugs, sulfaphenazole showed the highest activity; the drugs' MIC values for A. fumigatus and C. neoformans var. grubii were, respectively, 64 g/ml and 4-8 g/ml. Among five C. neoformans var. grubii strains, strains IFM 40216 and 40215 showed the highest susceptibility against sulfaphenazole, with MIC values of ≤ 4 g/ml. To our knowledge, this is the first report of the demonstration of in vitro antifungal activity of sulfa drugs against C. neoformans. Our preliminary studies show in vitro synergistic effects of sulfaphenazole and azole type antifungals. Coupled with in vitro antifungal activity of sulfa drugs and their possible synergistic effect with azole-type antifungals, sulfa drugs are inferred to be worthy of further in vivo evaluation as antifungal agents, especially against infections of C. neoformans var. grubii because sulfa drugs have a different action mechanism against fungi than azole type antifungals, whose action site is an ergosterol biosynthesis.
